fda drug shortages semaglutide injection shortage resolved 2025 says of Ozempic and Wegovy is over after more than two years Out of Shortage, Into Controversy:

Tirzepatide (Mounjaro) is licensed for type 2 diabetes

Efforts to reduce production costs (eg, cheaper injection devices, non-injectable formulations) and to explore generic formulations could improve affordability and expand global access to these therapies.119 Cost-effectiveness analyses are essential to justify the widespread use of GLP-1RAs

doi: 10.1159/000485132

Non-GLP-1 Diabetes Medications Options If GLP-1 receptor agonists dont work, other diabetes meds are available: Alternative Weight Management Approaches Theres more to managing weight than just meds

Gut Conditions That Can Interfere With Weight Loss Many people struggling with metabolic issues also experience underlying gastrointestinal dysfunction